10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,106 | -26.1% | 9,045 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $505,073 | -14.8% | 9,045 | -14.9% | 0.00% | 0.0% |
| Q1 2023 | $593,103 | -36.9% | 10,631 | -58.8% | 0.00% | -66.7% |
| Q4 2022 | $939,350 | -86.7% | 25,778 | -89.6% | 0.00% | -85.7% |
| Q3 2022 | $7,050,000 | +40.0% | 247,528 | +122.5% | 0.02% | +50.0% |
| Q2 2022 | $5,034,000 | +251600.0% | 111,233 | +347503.1% | 0.01% | – |
| Q1 2022 | $2,000 | -100.0% | 32 | -99.9% | 0.00% | -100.0% |
| Q4 2020 | $7,174,000 | +473.0% | 50,662 | +404.4% | 0.02% | +400.0% |
| Q3 2020 | $1,252,000 | – | 10,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |